The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.
The Partnership for Safe Medicines (PSM) applauds the passage of H.R. 5663 – the Safeguarding Therapeutics Act. The bipartisan bill, introduced by Congressman Brett Guthrie (KY-02-R) and Congressman Eliot Engel (NY-16-D), was passed via unanimous consent in the Senate on December 8th.
This editorial by the Sun Sentinel Editorial Board was published in The Sun Sentinel on December 9, 2020. The Editorial Board consists of Editorial Page Editor Rosemary O’Hara, Dan Sweeney, Steve Bousquet and Editor-in-Chief Julie Anderson. There Go Those Cheaper Drugs. Remember Florida’s plan to save money by importing prescription drugs in bulk from…
In PSM’s round-up this week: Canada banned exporting drugs to the U.S. if it will cause drug shortages at home, the FTC warns about fake COVID-19 testing centers, several large counterfeit pill busts, and more.
On Tuesday, December 2, 2020, New Mexico conducted their one and only public hearing on their plan to import medicine from Canada (over Canada’s objections). While the hearing was largely a formality, there was some interesting testimony.
Would you fly 6,000 miles to meet with a stranger who could be your new literal partner in crime? In April 2019, two Ukrainians did just that. While they dreamed of getting their counterfeit medicines into the legitimate U.S. drug supply chain, that dream was thwarted by the hard work and perseverance of federal investigators in Immigration and Customs Enforcement’s Homeland Security Investigations (HSI).
In an analysis of 50 prospective drugs, Maine’s Medicaid program found that it would lose nearly a million additional dollars ($927,983.28, to be exact) importing these drugs from Canada. How can this be? For many reasons, Canada is not the land of cheap drugs people think it is.
Today, PhRMA, The Partnership for Safe Medicines and Council for Affordable Health Coverage initiated litigation in the U.S. District Court for the District of Columbia challenging action by HHS and FDA permitting pharmacists and wholesalers, pursuant to state-sponsored programs, to import certain prescription drugs from Canada into the United States without drug manufacturers’ authorization or oversight.
In PSM’s round-up this week: Government authorities take legal action against COVID scammers; an insurance broker (allegedly) decided to open his own unlicensed pharmacy; ongoing counterfeit medicine news, and more.
In PSM’s round-up this week: An analysis of New Mexico’s draft drug importation plan, reports on COVID-19 fraud, and this week in counterfeit medicine news.
The state of New Mexico released a draft of its Canadian drug importation plan. PSM analyzed the plan, paying particular attention to concerns pharmacists might have about how drug importation might affect their patients and business…